Azithromycin as an adjunct Prophylactic drug for prevention Of surgical site infection in Caesarean delivery-a randomized Control trial

Abstract

INTRODUCTION: Caesarean section rates have increased worldwide and have been predicted to continue increasing over the current decade. At the present moment, caesarean section is responsible for almost twenty-one percent of all births, which is equivalent to nearly one birth out of every five women. A caesarean section is one of the most common surgical procedures that has been linked to an increased risk of surgical site infection. The purpose of the study is to study whether addition of azithromycin to standard antibiotic prophylaxis before skin incision would decrease the incidence of surgical site infection after caesarean section.